Using artificial intelligence, doctors have found a way to give people who lost their voice to ALS the ability to speak again ...

A New York-based neurotech startup, Synchron, successfully implanted its brain-computer interface into a blood vessel on the ...

For columnist Kristin Neva, whose husband, Todd, has ALS, everyday moments like her son's football game are filled with both ...

It's gained greater awareness, thanks to grass roots initiatives. Learn about ALS based on a patient's experience and a ...

Former New Orleans Saints player Steve Gleason and his wife Michel talk about how ALS has changed their lives, relive his ...

To be able to manage important aspects of my environment and control access to entertainment gives me back the independence ...

ALS, MS, post-traumatic brain injury? This biotech company has a target choice to make for an upcoming clinical trial — and ...

Steve Gleason, a former NFL safety renowned for his iconic punt block in 2006, was diagnosed with ALS in 2011. He established ...

The CEO Soak is on Thursday, Sept. 19 from 1 p.m. – 3 p.m. in St. Petersburg. People can sign up for the cause and help raise funds to beat the disease.

People with rare genetic variants linked to degenerative brain disorders like Parkinson's disease are at increased risk of ...

A chance encounter with an inspiring ALS patient, prompted Alon Ben-Noon to set up NeuroSense Therapeutics, a startup ...

The Muscular Dystrophy Association (MDA) is proud to announce a new clinical research grant of $500,000 over three years, awarded to Sabrina Paganoni, MD, PhD, of Massachusetts General Hospital (MGH).